Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidilizumab and Gemcitabine in Resected Pancreatic Cancer
NCT01313416Phase 2Terminated
- Sponsor
- Augusta University
- Start
- Sep 2012
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
A Phase 2 trial of pidilizumab in pancreatic cancer (PC), sponsored by Augusta University. Started Sep 2012; status: terminated.
02
Drugs
pidilizumab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01313416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313416.